OncoDaily’s Post

Highlights of the 5th SIOPE Annual Meeting in Milan - SIOP Europe, the European Society for Paediatric Oncology (SIOPE) #SIOPE #Cancer #CancerResearch #OncoDaily #Oncology #PediatricOncology #SIOPE

A very comprehensive and well put-together summary of

Counting down to #TxSCO2024 in San Antonio! Excited to be speaking at the Texas Society of Clinical Oncology Annual Conference in San Antonio on September 20 and 21, 2024. Some of the topics being covered: - Policy & Legislative Updates - State of Oncology Update from ASCO President Robin Zon, MD - Clinical Applications of AI - Clinical Trial Diversity - Updates in Metastatic Breast Cancer - Gastrointestinal Cancer - Clinical Wellbeing - Cybersecurity - Nurse Navigation Register here: https://loom.ly/CTLgMY0 #Oncology #CancerCare #BiggerinTexas

Here is a pre-print of a review article on TNBC from our group. Sushmitha Sriramulu is the first author. Thanks for the contributions Shivani T. and for collaborations Corey Speers. https://lnkd.in/emRmpBW7

This book is a story and a journey towards breaking stereotypes in communication within families and overcoming social-cultural barriers in Africa - Christian Ntizimira #Cancer #OncoDaily #Oncology #WorldBookDay

Always promoting the importance of sun protection...

Think biG and be courageous! Will glioblastoma, “the hardest nut to crack”, prove amenable to combined neoantigen plus checkpoint inhibitor immunotherapy? It’s no secret that treating glioblastoma has proven to be one the most challenging tumors, among a list that also includes melanoma. For at least the last 26 years that I’m familiar with since my mom’s brief encounter, GBM patients have faced a futile and bleak prognosis with little change in the standard of care. But as we are beginning to appreciate, the Moderna-Merck Phase 2 clinical trial combining checkpoint inhibitor immunotherapy, Keytruda, with an mRNA neoantigen, personal cancer vaccine therapy strategy demonstrated remarkable promise in difficult to treat, high-risk melanoma patients. A bold new chapter in this developing story is being written in Australia using a similar strategy for GBM. Though still an “n=1 pilot program,” this moving, tag-team summary presentation offers a glimpse of marvel and hope for patients that today face the bleak reality of a terminal illness. https://lnkd.in/gpAAknCt

Check out our new review on:

Great research John. Evidence suggests that similar impacts have been in other disorders such as diabetes. The COVID-19 pandemic has had profound impacts on healthcare delivery, and one of the critical areas affected has been the timely diagnosis and management of diabetes. During the pandemic, many individuals faced delays in accessing routine medical care, leading to late diagnoses and complications in diabetes management. For people living with diabetes, these delays have resulted in significant health risks. With routine appointments postponed or canceled, many missed essential screenings and monitoring. This lack of regular medical oversight has led to worsened glycemic control, increased hospitalizations, and severe complications such as cardiovascular issues, neuropathy, and retinopathy. The disruption in healthcare services also meant that many individuals could not receive timely education and support for diabetes management. This situation exacerbated stress and anxiety, further complicating the condition. As we navigate the post-pandemic landscape, it's crucial to prioritize catching up on missed care, ensuring timely interventions, and supporting patients in managing their diabetes effectively. The pandemic has underscored the importance of resilient healthcare systems and the need for innovative solutions to ensure continuity of care even during global crises. By learning from these experiences, we can better prepare and adapt to future challenges, ensuring that individuals with diabetes receive the care and support they need without interruption. #DiabetesCare #COVID19Impact #HealthcareInnovation #ChronicDiseaseManagement #PatientSupport #HealthcareResilience